Jian An

2.3k total citations · 1 hit paper
37 papers, 1.5k citations indexed

About

Jian An is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jian An has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Jian An's work include Ubiquitin and proteasome pathways (5 papers), Cancer-related molecular mechanisms research (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Jian An is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Cancer-related molecular mechanisms research (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Jian An collaborates with scholars based in China, United States and Japan. Jian An's co-authors include Long Yu, Chenji Wang, Eric S. Fischer, Katherine A. Donovan, Haojie Huang, Chengping Hu, Yibin Deng, Mark P. Jedrychowski, Zhixiang He and Stephen L. DeAngelo and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jian An

33 papers receiving 1.5k citations

Hit Papers

Plasticity in binding confers selectivity in ligand-induc... 2018 2026 2020 2023 2018 100 200 300 400

Peers

Jian An
Olena Barbash United States
Ming Song China
Martin L. Campbell United States
Manoj Kumar Kashyap United States
Daniel Triner United States
Rita Humeniuk United States
Ye Xu China
Olena Barbash United States
Jian An
Citations per year, relative to Jian An Jian An (= 1×) peers Olena Barbash

Countries citing papers authored by Jian An

Since Specialization
Citations

This map shows the geographic impact of Jian An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian An more than expected).

Fields of papers citing papers by Jian An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian An. The network helps show where Jian An may publish in the future.

Co-authorship network of co-authors of Jian An

This figure shows the co-authorship network connecting the top 25 collaborators of Jian An. A scholar is included among the top collaborators of Jian An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian An. Jian An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
An, Jian, Han Li, Bojie Chen, et al.. (2025). Guanine-Quadruplex-Engineered crRNA Enables Light-Activated CRISPR/Cas12a System for Robust One-Pot Viral Assay. Analytical Chemistry. 97(48). 26580–26589. 1 indexed citations
2.
Zhang, Ziyu, Li Li, Yang Gao, et al.. (2023). Immune characteristics associated with lymph node metastasis in early-stage NSCLC. Cellular Oncology. 47(2). 447–461.
3.
Yang, Jinjing, et al.. (2022). A Tryptophan Metabolite of the Microbiota Improves Neovascularization in Diabetic Limb Ischemia. Frontiers in Cardiovascular Medicine. 9. 910323–910323. 10 indexed citations
4.
Liu, Shiqing, Chengping Hu, Min Li, et al.. (2022). Estrogen receptor beta promotes lung cancer invasion via increasing CXCR4 expression. Cell Death and Disease. 13(1). 70–70. 33 indexed citations
5.
Guo, Wenyu, Shuo Huang, Jian An, et al.. (2022). Ultrasound-Mediated Antitumor Therapy via Targeted Acoustic Release Carrier of Carbon Monoxide (TARC-CO). ACS Applied Materials & Interfaces. 14(45). 50664–50676. 16 indexed citations
7.
Jiang, Juan, Wei Yang, Wenzhong Peng, et al.. (2021). Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study. Infectious Diseases and Therapy. 10(3). 1733–1745. 68 indexed citations
8.
Chen, Songming, et al.. (2021). A Novel Integrated Metabolism-Immunity Gene Expression Model Predicts the Prognosis of Lung Adenocarcinoma Patients. Frontiers in Pharmacology. 12. 728368–728368. 6 indexed citations
9.
Nowak, Radosław P., Stephen L. DeAngelo, Dennis L. Buckley, et al.. (2018). Plasticity in binding confers selectivity in ligand-induced protein degradation. Nature Chemical Biology. 14(7). 706–714. 427 indexed citations breakdown →
10.
Weng, Liang, Yipeng Han, Atsushi Enomoto, et al.. (2018). Negative regulation of amino acid signaling by MAPK-regulated 4F2hc/Girdin complex. PLoS Biology. 16(3). e2005090–e2005090. 11 indexed citations
11.
Yang, Yinhui, Dejie Wang, Jian An, et al.. (2017). Loss of FOXO1 Cooperates with TMPRSS2–ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion. Cancer Research. 77(23). 6524–6537. 47 indexed citations
12.
Tang, Yongjun, Ruoxi He, Jian An, et al.. (2017). lncRNA XIST interacts with miR-140 to modulate lung cancer growth by targeting iASPP. Oncology Reports. 38(2). 941–948. 51 indexed citations
13.
Li, Jingjing, Qihua Gu, Jian An, et al.. (2016). EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation. Oncology Reports. 35(4). 2339–2347. 40 indexed citations
14.
Tang, Yongjun, Ruoxi He, Jian An, et al.. (2016). The effect of H19-miR-29b interaction on bleomycin-induced mouse model of idiopathic pulmonary fibrosis. Biochemical and Biophysical Research Communications. 479(3). 417–423. 45 indexed citations
15.
Qu, Jingjing, Min Li, Jian An, et al.. (2015). MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling. International Journal of Oncology. 47(6). 2141–2152. 76 indexed citations
16.
Cheng, Tianli, Chengping Hu, Huaping Yang, Liming Cao, & Jian An. (2014). Transforming growth factor-β-induced miR-143 expression in regulation of non-small cell lung cancer cell viability and invasion capacity in vitro and in vivo. International Journal of Oncology. 45(5). 1977–1988. 21 indexed citations
17.
An, Jian, Chenji Wang, Yibin Deng, Long Yu, & Haojie Huang. (2014). Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants. Cell Reports. 6(4). 657–669. 192 indexed citations
18.
Xia, Ning, et al.. (2013). Analysis ofEGFR,EML4-ALK,KRAS, andc-METmutations in Chinese lung adenocarcinoma patients. Experimental Lung Research. 39(8). 328–335. 53 indexed citations
19.
An, Jian, Xiang-hua Liu, Mingjun Zhang, et al.. (2011). SNIP1: a new activator of HSE signaling pathway. Molecular and Cellular Biochemistry. 362(1-2). 1–6. 8 indexed citations
20.
Zhang, Pingzhao, Chenji Wang, Kun Gao, et al.. (2010). The Ubiquitin Ligase Itch Regulates Apoptosis by Targeting Thioredoxin-interacting Protein for Ubiquitin-dependent Degradation. Journal of Biological Chemistry. 285(12). 8869–8879. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026